Fingerprint
Dive into the research topics of 'Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: Final survival analysis of a phase III randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically